Retina/Vitreous News

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Paulo E. Stanga, MD, shares the benefits of the Silverstone device with ultra-widefield OCT angiography.

In an analysis of more than 3,100 older adults, low-dose aspirin administered for 3 years did not affect the incidence or progression of age-related macular degeneration, according to study results published in JAMA Ophthalmology.

Verana Health launched a real-world dataset for patients with uveitic macular edema, according to a press release.

Catch up on the top Healio Video Perspectives from this year’s Association for Research in Vision and Ophthalmology meeting.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema.

As Healio’s coverage of the Association for Research in Vision and Ophthalmology meeting winds down, catch up on this year’s most popular articles.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Mark R. Barakat, MD, discusses post hoc findings on IOP in patients receiving aflibercept 8 mg for diabetic macular edema in the PHOTON trial.

Merck will acquire EyeBio through a subsidiary in an agreement potentially valued at $3 billion, according to a press release.

A phase 2 clinical study of RZ402, a potential oral therapy for diabetic macular edema, met its primary endpoints of safety and reduction in central subfield thickness, according to a press release from Rezolute.

In June, retina experts from around the world will convene in Park City, Utah, to discuss ongoing clinical trials, best trial practices and recent data at Clinical Trials at the Summit.